Lindbrook Capital, LLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$3,812
-21.2%
3690.0%0.00%
-100.0%
Q2 2023$4,838
+17.3%
3690.0%0.00%
Q1 2023$4,125
+32.6%
3690.0%0.00%
Q4 2022$3,111
+3.7%
369
+85.4%
0.00%
-100.0%
Q3 2022$3,000199
+1226.7%
0.00%
Q2 2022$015
-11.8%
0.00%
Q1 2022$0170.00%
Other shareholders
PULMONX CORP shareholders Q3 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders